Future directions in adjuvant therapy for stage III colon carcinoma

ONCOLOGY

Volumn 15, Issue 3 SUPPL. 5, 2001, Pages 31-36

  Pitot, Henry C ^a,c   Goldberg, Richard M ^a,b  

^a Division of Medical Oncology   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; COLON TUMOR; FORECASTING; HUMAN; IMMUNOTHERAPY; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FLUOROURACIL; FORECASTING; HUMAN; IMMUNOTHERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 0035292311     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Garfinkel L, Mushinski M: U.S. Cancer incidence. Mortality and survival: 1973-1996. Stat Bull 80:23-32, 1999.
2. Cancer Facts and Figures 2000. Atlanta, American Cancer Society, 2000.
3. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC: Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA 259:3571-3578, 1988.
4. Laurie JA, Moertel CG, Fleming TR, et al: Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7:1447-1456, 1989.
5. Moertel CG, Fleming TR, MacDonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl J Med 322:352-358, 1990.
6. Moertel CG, Fleming TR, Macdonald JS, et al: Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 122:321-326, 1995.